174 related articles for article (PubMed ID: 6380622)
1. Deferoxamine: a reversible S-phase inhibitor of human lymphocyte proliferation.
Lederman HM; Cohen A; Lee JW; Freedman MH; Gelfand EW
Blood; 1984 Sep; 64(3):748-53. PubMed ID: 6380622
[TBL] [Abstract][Full Text] [Related]
2. The inhibitory effect of deferoxamine on DNA synthesis in human lymphocytes.
Wang ST; Jin KL; Li TH
Chin Med J (Engl); 1989 Dec; 102(12):902-5. PubMed ID: 2517733
[TBL] [Abstract][Full Text] [Related]
3. Effect of iron deficiency and desferrioxamine on DNA synthesis in human cells.
Hoffbrand AV; Ganeshaguru K; Hooton JW; Tattersall MH
Br J Haematol; 1976 Aug; 33(4):517-26. PubMed ID: 1009024
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of proliferation of human leukaemic cell populations by deferoxamine.
Foa P; Maiolo AT; Lombardi L; Villa L; Polli EE
Scand J Haematol; 1986 Jan; 36(1):107-10. PubMed ID: 3485303
[TBL] [Abstract][Full Text] [Related]
5. Iron deprivation decreases ribonucleotide reductase activity and DNA synthesis.
Furukawa T; Naitoh Y; Kohno H; Tokunaga R; Taketani S
Life Sci; 1992; 50(26):2059-65. PubMed ID: 1608289
[TBL] [Abstract][Full Text] [Related]
6. Novel uses of deferoxamine.
Weinberg K
Am J Pediatr Hematol Oncol; 1990; 12(1):9-13. PubMed ID: 2178461
[TBL] [Abstract][Full Text] [Related]
7. Growth inhibition of bloodstream forms of Trypanosoma brucei by the iron chelator deferoxamine.
Breidbach T; Scory S; Krauth-Siegel RL; Steverding D
Int J Parasitol; 2002 Apr; 32(4):473-9. PubMed ID: 11849643
[TBL] [Abstract][Full Text] [Related]
8. Iron and deferoxamine in lymphocyte blastogenesis.
Lipsky JJ; Lietman PS
J Immunopharmacol; 1980; 2(2):179-87. PubMed ID: 6821550
[TBL] [Abstract][Full Text] [Related]
9. Proceedings: Effect of iron deficiency on DNA synthesis.
Hoffbrand AV; Ganeshaguru K; Tattersall MH; Tripp E
Clin Sci Mol Med; 1974 Feb; 46(2):12P. PubMed ID: 4817251
[No Abstract] [Full Text] [Related]
10. Growth, ribonucleotide reductase and metals in murine leukemic lymphocytes.
Oblender M; Carpentieri U
J Cancer Res Clin Oncol; 1991; 117(5):444-8. PubMed ID: 1890140
[TBL] [Abstract][Full Text] [Related]
11. Exposure to cigarette tar inhibits ribonucleotide reductase and blocks lymphocyte proliferation.
McCue JM; Link KL; Eaton SS; Freed BM
J Immunol; 2000 Dec; 165(12):6771-5. PubMed ID: 11120797
[TBL] [Abstract][Full Text] [Related]
12. The effect of desferrithiocin, an oral iron chelator, on T-cell function.
Bierer BE; Nathan DG
Blood; 1990 Nov; 76(10):2052-9. PubMed ID: 2242426
[TBL] [Abstract][Full Text] [Related]
13. Iron, desferrioxamine, and ATP interactions in proliferating lymphocytes and B-cell lines.
Latunde-Dada GO; Young SP
Biochem Soc Trans; 1995 May; 23(2):213S. PubMed ID: 7672233
[No Abstract] [Full Text] [Related]
14. Cytidine 5'-diphosphate reductase activity in phytohemagglutinin stimulated human lymphocytes.
Tyrsted G; Gamulin V
Nucleic Acids Res; 1979 Jan; 6(1):305-19. PubMed ID: 424294
[TBL] [Abstract][Full Text] [Related]
15. Modulation of transferrin receptor expression by inhibitors of nucleic acid synthesis.
Hedley D; Rugg C; Musgrove E; Taylor I
J Cell Physiol; 1985 Jul; 124(1):61-6. PubMed ID: 2413049
[TBL] [Abstract][Full Text] [Related]
16. Cell cycle synchronization and growth inhibition by 3-hydroxypyridin-4-one iron chelators in leukemia cell lines.
Hoyes KP; Hider RC; Porter JB
Cancer Res; 1992 Sep; 52(17):4591-9. PubMed ID: 1511427
[TBL] [Abstract][Full Text] [Related]
17. Induction of embryonal carcinoma cell differentiation by deferoxamine, a potent therapeutic iron chelator.
Tanaka T; Muto N; Ido Y; Itoh N; Tanaka K
Biochim Biophys Acta; 1997 Jun; 1357(1):91-7. PubMed ID: 9202179
[TBL] [Abstract][Full Text] [Related]
18. Effect of deferoxamine on DNA synthesis, DNA repair, cell proliferation, and differentiation of HL-60 cells.
Kaplinsky C; Estrov Z; Freedman MH; Gelfand EW; Cohen A
Leukemia; 1987 May; 1(5):437-41. PubMed ID: 3312841
[TBL] [Abstract][Full Text] [Related]
19. Control of the growth of leukemic cells (L1210) through manipulation of trace metals.
Oblender M; Carpentieri U
Anticancer Res; 1991; 11(4):1561-4. PubMed ID: 1746914
[TBL] [Abstract][Full Text] [Related]
20. Effect on ribonucleotide reductase of novel lipophilic iron chelators: the desferri-exochelins.
Hodges YK; Antholine WE; Horwitz LD
Biochem Biophys Res Commun; 2004 Mar; 315(3):595-8. PubMed ID: 14975742
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
